Second Generation Human Milk Oligosaccharides Blend Study

NCT03722550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 789

Last updated 2022-02-17

No results posted yet for this study

Summary

The aim of this trial is to show that infants fed these new formulas, containing a blend of 5 Human Milk Oligosaccharides (HMOs), allow for growth in line with infants fed formulas without HMOs.

There will be different groups in the trial: three formula-fed groups and a breastfed group.

Conditions

  • Healthy Infants

Interventions

OTHER

Starter Infant Formula, Follow-up Formula, and Growing-up Milk Supplemented With a Blend of Five Human Milk Oligosaccharides

Study formulas are administered orally, ad libitum, from enrollment until 15 months of age

OTHER

Breast-feeding

Exclusive Breast-feeding up to 4 months of age

OTHER

Standard Starter Infant Formula, Follow-up Formula, and Growing-up Milk

Standard Study formulas are administered orally, ad libitum, from enrollment until 15 months of age

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Aleksander Krasnow, Lek. Med. · Gdańskie Centrum Zdrowia Sp. Z o.o.

  • Wiesław Olechowski, Dr n.med. · ALERGO-MED Specjalistyczna Przychodnia Lekarska Sp. Z o.o.

  • Sylwia Korzyńska, MD · Centrum Medyczne Pratia Ostrolęka

  • Anna Płoszczuk, Dr. n.med. · Prywatna Praktyka Lekarska Gabinet Pediatryczno-Alergologiczny Anna Płoszczuk

  • Magdalena Sidorowicz, Dr. · Centrum Medyczne Pratia Warszawa

  • Grażyna Jasieniak-Pinis, Lek. Med. · ATOPIA Niepubliczny Zakład Opieki Zdrowotnej Poradnie Specjalistyczne

  • Bartosz Korczowski, PhD MD Dr · Korczowski Bartosz Gabinet Lekarski

  • Piotr Korbal, Dr. · Szpital Uniwersytecki nr 2 Im. Dr Jana Biziela w Bydgoszczy Oddział Kliniczny Noworodków, Wcześniaków z Intensywną Terapią Noworodka wraz z

  • Marta Żołnowska, Lek. Med. · Centrum Medyczne Plejady

  • Bogusław Cimoszko, Lek. Med. · Clinical Vitae Sp z o.o. Poradnia Podstawowej Opieki Zdrowotnej

  • Wanda Furmaga-Jabłonska, Prof. · Uniwersytecki Szpital Dziecięcy w Lublinie

  • Marzena Nowak, Dr. · Centrum Medyczne PROMED

  • Georgios Marek Vasilopoulos, Dr. · Centrum Innowacyjnych Terapii Sp. z o.o.

  • Viktor Bauer, MD · Dr. Kenessey Albert Kórház-Rendelőintézet

  • Robert Simkó, MD · Futurenest Kft.

  • István Laki, MD · Kanizsai Dorottya Kórház

  • Éva Kovács, MD · Házi Gyermekorvosi Rendelő / Babadoki Kft.

  • Éva Szabó, MD · Csolnoky Ferenc Kórház

  • István Tokodi, MD · Mentaház Magánorvosi Központ Kft.

  • Zsuzsanna Tengelyi, MD · Clinexpert Kft.

  • Katalin Fister, MD · Clinexpert Gyöngyös Egészségügyi Szolgáltató Kft.

  • Anton Bilev, MD · MC ''Sveti Ivan Rilski - Chudotvorets''

  • Miroslava Bosheva, MD · University Multiorofile Hospital for active treatment Sveti Georgi EAD, Pediatric clinic

  • Toni Grigorov, MD · Multiprofile Hospital for Active Treatment City Clinic - Sveti Georgi EOOD,Department of Paediatrics,

  • Rositsa Karcheva-Beloeva, MD · Medical Center-1-Sevlievo

  • Margarita Koleva, MD · Diagnostic-consultative center Ritam TR

  • Stelyana Kraeva, MD · Alitera -Med-Medical Center

  • Olga Nikolova, MD · Multiprofile Hospital for Active Treatment Sveti Ivan Rilski Kozloduy,Department of Pediatrics

  • Tatyana Stoeva, MD · Medical Centre - Izgrev

  • Irina Popova, MD · University Hospital 'Deva Maria', Department for Naonatology

  • Svilen Dosev, MD · Multiprofile Hospital for Active treatment Ruse AD, Department of Paediatrics

  • Stefan Banov, MD · SMA Dr Stefan Banov

  • Sirma Dimitrova, MD · Medical Center Excelsior

  • Malgorzata Arciszewska, MD · Poliklinika Ginekolo.-Poloznicza

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Days
Max Age
21 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-19
Primary Completion
2021-11-05
Completion
2022-01-19

Countries

  • Bulgaria
  • Hungary
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03722550 on ClinicalTrials.gov